Millennium Pharmacon Current Valuation vs. Net Income
| SDPC Stock | IDR 137.00 1.00 0.72% |
For Millennium Pharmacon profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Millennium Pharmacon to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Millennium Pharmacon International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Millennium Pharmacon's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Millennium Pharmacon International over time as well as its relative position and ranking within its peers.
Millennium |
Millennium Pharmacon Net Income vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Millennium Pharmacon's current stock value. Our valuation model uses many indicators to compare Millennium Pharmacon value to that of its competitors to determine the firm's financial worth. Millennium Pharmacon International is currently regarded number one company in current valuation category among its peers. It also is currently regarded as top stock in net income category among its peers making up about 0.01 of Net Income per Current Valuation. The ratio of Current Valuation to Net Income for Millennium Pharmacon International is roughly 86.54 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Millennium Pharmacon's earnings, one of the primary drivers of an investment's value.Millennium Current Valuation vs. Competition
Millennium Pharmacon International is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 10.59 Trillion. Millennium Pharmacon holds roughly 828.27 Billion in current valuation claiming about 8% of equities under Health Care industry.
Millennium Net Income vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Millennium Pharmacon |
| = | 828.27 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Millennium Pharmacon |
| = | 9.57 B |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Millennium Net Income Comparison
Millennium Pharmacon is currently under evaluation in net income category among its peers.
Millennium Pharmacon Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Millennium Pharmacon, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Millennium Pharmacon will eventually generate negative long term returns. The profitability progress is the general direction of Millennium Pharmacon's change in net profit over the period of time. It can combine multiple indicators of Millennium Pharmacon, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Millennium Pharmacon operates under Medical Distribution classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 1092 people.
Millennium Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Millennium Pharmacon. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Millennium Pharmacon position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Millennium Pharmacon's important profitability drivers and their relationship over time.
Use Millennium Pharmacon in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Millennium Pharmacon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Millennium Pharmacon will appreciate offsetting losses from the drop in the long position's value.Millennium Pharmacon Pair Trading
Millennium Pharmacon International Pair Trading Analysis
The ability to find closely correlated positions to Millennium Pharmacon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Millennium Pharmacon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Millennium Pharmacon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Millennium Pharmacon International to buy it.
The correlation of Millennium Pharmacon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Millennium Pharmacon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Millennium Pharmacon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Millennium Pharmacon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Millennium Pharmacon position
In addition to having Millennium Pharmacon in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Communication Thematic Idea Now
Communication
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Communication theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Millennium Stock
To fully project Millennium Pharmacon's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Millennium Pharmacon at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Millennium Pharmacon's income statement, its balance sheet, and the statement of cash flows.